Physical dependence on benzodiazepines: differences within the class
Open accessAbstract
Concern about physical dependence seems to be the major limiting factor in the long-term treatment with benzodiazepines (BZD). The severity of the withdrawal syndrome is determined by multiple factors, e.g. dose, duration of use, frequency of dose interval, mode of discontinuation, the pharmacologic characteristics of the BZD, personality and previous or concurrent use of cross-dependent drugs and/or alcohol. There is evidence that BZD with a short elimination half-life cause a more severe withdrawal syndrome than those with a long elimination half-life. Besides pharmacokinetic properties, pharmacodynamic factors such as potency may also covary with the liability of a BZD to induce physical dependence. There is an increasing body of literature indicating that quickly eliminated, high potency BZD such as alprazolam and lorazepam may be more likely to cause severe withdrawal reactions than slowly eliminated compounds such as diazepam or less potent derivatives such as oxazepam. Alprazolam seems to play an exceptional role, insofar as relatively soon after its introduction to the market a number of case reports of withdrawal psychoses, seizures and intense rebound anxiety were published. Data reviewed from the literature correspond well with the results of interviews conducted with 31 clinicians across the United States with experience in detoxifying patients dependent on BZD, 84% of these physicians mentioning alprazolam as especially problematic with respect to the intensity and/or duration of the withdrawal syndrome.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The prevalence of rebound insomnia is significantly lower in all benzodiazepines compared to triazolam.
“The prevalence of rebound insomnia was found to be significantly lower in all benzodiazepines compared to triazolam [52, 60-69] and was lower than that with triazolam.”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [65]
Cites
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369 · see citing works
Abuse liability of benzodiazepines.
Woods, J. H., Katz, J. L., & Winger, G. D. (1987) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06658-x · Cited by 317 · see citing works
Benzodiazepine withdrawal symptoms and propranolol
TYRER, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92861-0 · Cited by 297 · see citing works
Benzodiazepine Dependence A Review of the Evidence
Owen, R. T., & Tyrer, P. J. (1983) · Drugs · doi:10.2165/00003495-198325040-00003 · Cited by 287 · see citing works
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.250.6.767 · Cited by 276 · see citing works
Long-term Diazepam Therapy and Clinical Outcome
Rickels, K. (1983) · JAMA · doi:10.1001/jama.1983.03340060045024 · Cited by 275 · see citing works
Gradual Withdrawal of Diazepam after Long-Term Therapy
Tyrer, P., Owen, R., & Dawling, S. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92355-3 · Cited by 271 · see citing works
Pecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204 · see citing works
CHRONIC BARBITURATE INTOXICATION
Isbell, H. (1950) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1950.02310250007001 · Cited by 189 · see citing works
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176 · see citing works
Discontinuation of alprazolam treatment in panic patients
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.3.303 · Cited by 172 · see citing works
Withdrawal Reaction From Long-term, Low-dosage Administration of Diazepam
Winokur, A. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140103012 · Cited by 156 · see citing works
Diazepam use among methadone maintenance patients: Patterns and dosages
Stitzer, M. L., Griffiths, R. R., McLellan, A. T., Grabowski, J. G., & Hawthorne, J. W. (1981) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(81)90061-2 · Cited by 151 · see citing works
Self-citationRebound insomnia. A potential hazard following withdrawal of certain benzodiazepines
Kales, A. (1979) · JAMA · doi:10.1001/jama.241.16.1692 · Cited by 136 · see citing works
Anxiolytics: Neurochemical, behavioral, and clinical perspectives
Honoré, T. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90504-7 · Cited by 114 · see citing works
Kales, A. (1979) · JAMA · doi:10.1001/jama.1979.03290420018017 · Cited by 101 · see citing works
Pharmacokinetic Determinants of Drug Abuse and Dependence
Busto, U. E., & Sellers, E. M. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611020-00004 · Cited by 89 · see citing works
Withdrawal syndrome with gradual tapering of alprazolam
Mellman, T. A., & Uhde, T. W. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1464 · Cited by 81 · see citing works
Depression following withdrawal from long-term benzodiazepine use: a report of four cases
Olajide, D., & LADER, M. H. (1984) · Psychological Medicine · doi:10.1017/s0033291700019899 · Cited by 69 · see citing works
Objective Determination of Benzodiazepine Use and Abuse in Alcoholics
Busto, U. E., Simpkins, J., Sellers, E. M., Sisson, B., & Segal, R. (1983) · British Journal of Addiction · doi:10.1111/j.1360-0443.1983.tb02531.x · Cited by 65 · see citing works
Seizures induced by abrupt discontinuation of alprazolam
Breier, A. F., Charney, D. S., & Nelson, J. C. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1606 · Cited by 65 · see citing works
Delirium and seizures due to abrupt alprazolam withdrawal: case report.
Levy, A. B. (1984) · PubMed · Cited by 64 · see citing works
Differential Efficacy of Unilateral and Bilateral ECT
FONTAINE, R., & YOUNG, T. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.8.1013-b · Cited by 62 · see citing works
Diazepam tapering in detoxification for high-dose benzodiazepine abuse
Harrison, M., Busto, U., Naranjo, C. A., Kaplan, H. L., & Sellers, E. M. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.214 · Cited by 57 · see citing works
Lorazepam withdrawal seizures.
Howe, J. G. (1980) · BMJ · doi:10.1136/bmj.280.6224.1163-a · Cited by 56 · see citing works
A Review of Alprazolam Withdrawal
Browne, J. L., & Hauge, K. J. (1986) · Annals of Pharmacotherapy · doi:10.1177/106002808602001102 · Cited by 55 · see citing works
Benzodiazepine Withdrawal Seizures: Analysis of 48 Case Reports
Fialip, J., Aumaitre, O., Eschalier, A., Maradeix, B., Dordain, G., & Lavarenne, J. (1987) · Clinical Neuropharmacology · doi:10.1097/00002826-198712000-00005 · Cited by 53 · see citing works
The Place of Benzodiazepines in Psychiatric Practice
Tyrer, P. J., & Murphy, S. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.6.719 · Cited by 52 · see citing works
Dependence as a limiting factor in the clinical use of minor tranquillizers
Tyrer, P. J. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90105-2 · Cited by 51 · see citing works
Benzodiazepine withdrawal seizures: analysis of 48 case reports.
Fialip, J., Aumaître, O., Eschalier, A., Maradeix, B., Dordain, G., & Lavarenne, J. (1987) · PubMed · Cited by 50 · see citing works
Alprazolam dependence in seven patients
Juergens, S. M., & Morse, R. M. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.625 · Cited by 48 · see citing works
Identification and management of benzodiazepine dependence.
Tyrer, P. J., & Seivewright, N. (1984) · PubMed · Cited by 45 · see citing works
Successful treatment of obsessive-compulsive disorder with ECT
Mellman, L. A., & Gorman, J. M. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.4.596 · Cited by 43 · see citing works
Benzodiazepines: Dependence and Withdrawal
Ayd, F. J. (1979) · JAMA · doi:10.1001/jama.1979.03300130045021 · Cited by 43 · see citing works
Sedative/Hypnotic Dependence: Patient Stabilization, Tolerance Testing, and Withdrawal
Perry, P. J., & ALEXANDER, B. K. (1986) · Annals of Pharmacotherapy · doi:10.1177/106002808602000702 · Cited by 41 · see citing works
Alprazolam withdrawal delirium unresponsive to diazepam: case report.
Zipursky, R. B., Baker, R. W., & Zimmer, B. (1985) · PubMed · Cited by 39 · see citing works
Seizures Following the Withdrawal of Alprazolam
Noyes, R., Perry, P. J., Crowe, R., Coryell, W. H., CLANCY, J., Yamada, T., & Gabel, J. (1986) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198601000-00009 · Cited by 38 · see citing works
Einarson, T., & Tyrer, P. J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90631-5 · Cited by 34 · see citing works
Diazepam Use by Patients in a Methadone Program – How Serious A Problem?
WOODY, G. E., Mintz, J., O'Hare, K., O’Brien, C. P., Greenstein, R. A., & Hargrove, E. (1975) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1975.10471526 · Cited by 33 · see citing works
A Case of Oxazepam (Serenid D) Dependence
Hanna, S. M. (1972) · The British Journal of Psychiatry · doi:10.1192/bjp.120.557.443 · Cited by 30 · see citing works
A Possible Oxazepam Abstinence Syndrome
Selig, J. W. (1966) · JAMA · doi:10.1001/jama.1966.03110210201057 · Cited by 27 · see citing works
The abuse potential of benzodiazepines with special reference to oxazepam
Bliding, Å. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb02395.x · Cited by 25 · see citing works
Another case of alprazolam withdrawal syndrome
Vital-Herne, J., Brenner, R., & LESSER, M. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.12.1515a · Cited by 15 · see citing works
Schmidt, L. G., Müller-Oerlinghausen, B., Schlünder, M., Seidel, M., & Platz, W. E. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1068341 · Cited by 12 · see citing works
Controlled Hypotension in Neurosurgery
Pooler, H. E. (1953) · BMJ · doi:10.1136/bmj.1.4820.1163-c · Cited by 9 · see citing works
Lorazepam Withdrawal and Seizures
Kahan, B. B., & Haskett, R. F. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.8.1011-a · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934 · see citing works
Robinson, T. E., & Kolb, B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08491.1997 · Cited by 704 · see citing works
(2004) · PubMed · Cited by 296 · see citing works
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works
Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models
Eissenberg, T. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00735.x · Cited by 152 · see citing works
Schultz, K. N., von Esenwein, S. A., Hu, M., Bennett, A. L., Kennedy, R. T., Musatov, S. A., Toran‐Allerand, C. D., Kaplitt, M. G., Young, L. J., & Becker, J. B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4647-08.2009 · Cited by 122 · see citing works
Benzodiazepines, Methadone and Buprenorphine: Interactions and Clinical Management
Lintzeris, N., & Nielsen, S. (2009) · American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00007.x · Cited by 109 · see citing works
Kan, C. C., Hilberink, S. R., & Breteler, M. H. M. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2003.12.007 · Cited by 81 · see citing works
Onn, S., & Grace, A. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02332.2000 · Cited by 72 · see citing works
Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland
Taipale, H. T., Särkilä, H., Tanskanen, A. J., Kurko, T., Taiminen, T. J., Tiihonen, J., Sund, R., Tuulio‐Henriksson, A., Saastamoinen, L., & Hietala, J. A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19029 · Cited by 59 · see citing works
Schweizer, E. E. (1995) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30026-1 · Cited by 43 · see citing works
Moylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822d0012 · Cited by 34 · see citing works
Pharmacotherapy of anxious disorders
Bourin, M., & Lambert, O. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.435 · Cited by 34 · see citing works
Benzodiazepine dependence among multidrug users in the club scene
Kurtz, S. P., Surratt, H. L., Levi‐Minzi, M. A., & Mooss, A. D. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.036 · Cited by 31 · see citing works
The role of alprazolam for the treatment of panic disorder in Australia
Moylan, S., Giorlando, F., Nordfjærn, T., & Berk, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867411432074 · Cited by 30 · see citing works
Popova, D., Ágústsdóttir, A., Lindholm, J., Mazulis, U., Akamine, Y., Castrén, E., & Karpova, N. N. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.04.002 · Cited by 26 · see citing works
Benzodiazepine Dependence among Young Adult Participants in the Club Scene Who Use Drugs
Kurtz, S. P., Buttram, M. E., & Surratt, H. L. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1269978 · Cited by 27 · see citing works
Initiation and long‐term use of benzodiazepines and Z‐drugs in bipolar disorder
Wingård, L., Taipale, H. T., Reutfors, J., Westerlund, A., Bodén, R., Tiihonen, J., Tanskanen, A. J., & Andersen, M. T. (2018) · Bipolar Disorders · doi:10.1111/bdi.12626 · Cited by 27 · see citing works
Correlates of Dependence and Beliefs About the Use of Hypnotics Among Zolpidem and Zopiclone Users
Yen, C., Yen, C., Ko, C., Hwang, T., Chen, C., Chen, T., Su, P., Chen, S., & Lin, J. (2014) · Substance Use & Misuse · doi:10.3109/10826084.2014.980955 · Cited by 25 · see citing works
Benzodiazepines in Geriatric Psychiatry
Høiseth, G., Kristiansen, K. M., Kvande, K., Tanum, L., Lorentzen, B., & Refsum, H. (2013) · Drugs & Aging · doi:10.1007/s40266-012-0045-9 · Cited by 22 · see citing works
Are Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder
Victorri‐Vigneau, C., Laforgue, E., Grall‐Bronnec, M., Guillou-Landréat, M., Rousselet, M., Guerlais, M., FAN‐Network, Feuillet, F., & Jolliet, P. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2025 · Cited by 21 · see citing works
Juergens, S. M. (1993) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30191-6 · Cited by 19 · see citing works
Diagnosis and Management of Generalized Anxiety Disorder
Roerig, J. L. (1999) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(15)30372-7 · Cited by 19 · see citing works
Deacon, R. M., Nielsen, S., Leung, S., Rivas, G., Cubitt, T. I. C., Monds, L. A., Ezard, N., Larance, B., & Lintzeris, N. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.06.006 · Cited by 18 · see citing works
Pomara, N., Willoughby, L. M., Ritchie, J., Sidtis, J. J., Greenblatt, D. J., & Nemeroff, C. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300365 · Cited by 18 · see citing works
Temte, V., Kjeldstadli, K., Bruun, L. D., Birdal, M., Bachs, L., Karinen, R., Middelkoop, G., Øiestad, E., & Høiseth, G. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bky062 · Cited by 15 · see citing works
Benzodiazepines in Psychiatric Emergency Settings
Shaner, R. (2000) · Psychiatric Annals · doi:10.3928/0048-5713-20000401-11 · Cited by 13 · see citing works
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
Reed, M. K., Murali, V., Sarpoulaki, N., Zavodnick, J. H., Hom, J. K., & Rising, K. L. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100106 · Cited by 12 · see citing works
The Combination of Metyrapone and Oxazepam for the Treatment of Cocaine and Other Drug Addictions
Goeders, N. E., Guerin, G. F., & Schmoutz, C. D. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00011-1 · Cited by 10 · see citing works
Clinical Pharmacokinetics and Pharmacodynamics of Anxiolytics and Sedative/Hypnotics
DeVane, C. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-27883-4_10 · Cited by 9 · see citing works
Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors
Gerak, L. R., Maguire, D. R., & France, C. P. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_265 · Cited by 8 · see citing works
Chen, T.-T., Ko, C., Chen, S., Yen, C., Su, P.-W., Hwang, T., Lin, J., & Yen, C. (2014) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2014.04.004 · Cited by 6 · see citing works
Managing Psychotic Illness in Young People: A Practical Overview
Tiffin, P. A. (2006) · Child and Adolescent Mental Health · doi:10.1111/j.1475-3588.2006.00418.x · Cited by 6 · see citing works
HOROWSKI, R. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02209-8 · Cited by 6 · see citing works
Oxazepam Cost-Savings Conversion
Dillon, C. L., Lopez, J. R., & Leyba, C. M. (2001) · Hospital Pharmacy · doi:10.1177/001857870103600611 · Cited by 4 · see citing works
Korkmaz, S., & Wahlström, G. (1999) · Journal of Studies on Alcohol · doi:10.15288/jsa.1999.60.546 · Cited by 4 · see citing works
Past, Present, and Future Pharmacological Therapies for Tinnitus
Allman, B. L., Schormans, A. L., Typlt, M., & Lobariñas, E. (2016) · Springer handbook of auditory research · doi:10.1007/978-3-319-40848-4_7 · Cited by 4 · see citing works
Samadi, A., Ansari, M. H. K., & Ulusu, N. N. (2017) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2017-0003 · Cited by 2 · see citing works
Original and Simple Protocol for Withdrawal of Benzodiazepines to Achieve Sustained Remission
Granato, P., Vinekar, S. S., Audrey, F., Philippe, P., Danel, T., & Cottencin, O. (2016) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2016.62024 · Cited by 1 · see citing works
Study design criteria for regulatory-based drug control action: Drug discrimination
Gauvin, D. V., & Zimmermann, Z. J. (2021) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2021.107073 · Cited by 1 · see citing works
Inui, Y., Yamamoto, M., Awasaki, Y., & Nishida, N. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00106-6 · Cited by 1 · see citing works
Mechanisms of Benzodiazepine Drug Dependence
Vgontzas, A. N., & Kales, A. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_19 · Cited by 1 · see citing works
Are rapid inpatient benzodiazepine detoxifications unsafe?
Robertson, M. S., & Bell, J. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb121899.x · Cited by 1 · see citing works
Behavioral Pharmacology of Sedatives, Hypnotics, and Anxiolytics
Rush, C. R., Hayes, C. A., & Higgins, S. T. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_28 · Cited by 1 · see citing works
Bossini, L., Borghini, E., & Fagiolini, A. M. (2013)
Epidemiological studies of medication use and effectiveness in bipolar disorder
Wingård, L. (2017) · Figshare
Шуб, Г. М., Владимирович, А. В., Сергеевич, Л. М., Добрейкин, Е. А., Алипов, Н. В., Александровна, П. Е., Raikova, S. V., & Георгиевна, Ш. О. (2011) · DOAJ (DOAJ: Directory of Open Access Journals)
Chapter 7. Sedatives, Hypnotics, or Anxiolytics
Blazes, C. K., & Leung, S. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg07
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_16
- Authors
- Wolf, B., & Griffiths, R. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Wolf, Barbara
- ORCID
- Griffiths, Roland R.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 29
- Issue
- 2
- Pages
- 153-156
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2112166915
- Cited by
- 49
- References
- 45
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 5 · 2014: 4 · 2013: 2 · 2012: 1
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Drug and Alcohol Dependence (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepine dependence, benzodiazepine withdrawal syndrome, alprazolam, lorazepam, diazepam, oxazepam, elimination half-life, drug potency, benzodiazepine detoxification, cross-dependence
- MeSH terms
- Benzodiazepines, Dose-Response Relationship, Drug, Half-Life, Humans, Substance Withdrawal Syndrome, Anti-Anxiety Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review